ALDH1A2 and neoplasm: The Kaplan–Meier plots demonstrated that the patients with lower ALDH1A2 expression, as well as patients with advanced tumor stage (stage III/IV), displayed shorter disease-free (p < 0.001) and overall (p < 0.001) survival (Figure 7A–D).